Translate page

The International CML Foundation (iCMLf) is a Foundation established in 2009 by a group of hematologists with a strong interest in CML. Our mission is to improve the outcomes for patients with CML globally. We are currently registered as a charitable foundation in England and Wales, however our charter is global.

What are our aims and priorities?

The aims of the iCMLf are to foster and coordinate global clinical and research collaborations and to improve clinical practice and disease monitoring in CML by sharing best practice CML management.

The iCMLf has three main priorities:

  1. Improve access to world-class CML education and best practice so that people with CML receive the best possible management
  2. Increase the availability of CML testing for accurate diagnosis and monitoring. Through this more peope with CML will have access to treatment.
  3. Establish global research networks and projects to change the treatment paradigm of CML. Through these we work towards a cure for CML.

All our activities improve the lives of people with CML. The ultimate vision of the iCMLf is that through our work we cure CML, eventually preventing and eradicating the disease. 

Who is the iCMLf for?

Everybody with an interest in CML!

How is the iCMLf governed and supported?

The iCMLf has:

Dr Syed Owais Ali, MD
(Rawalpindi, Pakistan)

John Goldman Conference Dr Ali Kopie'I’m very lucky to have the opportunity to come to this conference. I have learned a lot by listening to the presentations and by interacting with people from other countries and from other universities and I now have the full picture in my mind. 

Back home in my country I will be sharing everything that I have seen and learned here and this will help us to treat our CML patients in the right way and to better serve our patients. (Dr Owais Ali, Pakistan)

034 ESH CML 2017 Kopie

Syed Owais Ali’s attendance at the John Goldman Conference on CML in Estoril in 2017 was supported by the iCMLf Goldman Fund. At a ceremony shortly after the opening of the conference, he received a certificate from the iCMLf chairman, Professor Tim Hughes.

Associate Professor Agnes Yong MBBCh(Hons) PhD MRCP (UK) FRCPath (UK) FRACP FRCPAAssociate Professor Agnes Yong

Clinical Associate Professor, University of Western Australia
Consultant Hematologist, Royal Perth Hospital
Senior Research Fellow, SAHMRI

Associate Professor Agnes Yong trained in Medicine at the Queen’s University of Belfast, UK. Following advanced training in clinical and laboratory haematology, and blood and marrow transplantation in London at the Hammersmith Hospital, she embarked on research on chronic myeloid leukaemia and obtained her PhD from The Imperial College, University of London.

After postdoctoral research at the National Institute of Health in Bethesda, Maryland, USA, she moved to Australia in 2010 and was Consultant Haematologist at the Royal Adelaide Hospital, with particular interests in chronic myeloid leukaemia, haematopoietic stem cell transplantation and survivorship. Agnes is also involved in clinical research in myeloma, leukaemia and lymphoma. She enjoys teaching and mentoring medical students and haematology trainees, and is a recipient of the Professor Derek Frewin AO citation for excellence in clinical teaching from the University of Adelaide.

Agnes moved to Perth in 2019 and is a Consultant Haematologist at Royal Perth Hospital, with affiliations at the University of Western Australia and the University of Adelaide. She is a recipient of multiple research grants, with multiple publications in chronic myeloid leukaemia and transplantation, and is Associate Editor of the British Journal of Haematology and Frontiers in immunology.

The iCMLf National Representatives

 

National Representatives of the iCMLf support the iCMLf initiatives at a national level.

 

The 36 iCMLf National Representatives are:

 

Australia Devendra Hiwase (Adelaide)
Argentina Eduardo Bullorsky (Buenos Aires)
Austria Peter Valent (Vienna)
Belgium Philippe Martiat (Brussels)
Brazil Ricardo Pasquini (Curitiba)
Canada Jeff Lipton (Toronto)
China He Huang (Zhejiang)
Croatia Boris Labar  (Zagreb)
Cuba Valia Pavon
Czech Rep Jiri Mayer (Brno)
England Nick Cross (Salisbury)
Finland Kimmo Porkka (Helsinki)
France Francois-Xavier Mahon (Bordeaux)
Germany Andreas Hochhaus (Jena)
Hong Kong Raymond Liang (Hong Kong)
India Hemant Malhotra (Jaipur)
Ireland Michael O’Dwyer (Galway)
Israel Arnon Nagler (Tel Hashomer)
Italy Giovanni Martinelli (Bologna)
Korea Dong Wook Kim (Seoul)
Lithuania Laimonas Griskevicius (Vilnius)
Malaysia Kian Meng Chang
Moldova Vasile Musteata
Netherlands Gert J. Ossenkoppele
New Zealand Peter Browett (Auckland)
Nigeria Muheez Durosinimi
Poland Andrzej Hellmann (Gdarisk)
Portugal Antonio Parreira
Russia Andrey Zaritskey (St. Petersburg)
Scotland Tessa Holyoake (Glasgow)
Serbia Andrija Bogdanovic (Belgrade)
South Africa Nic Novitzky (Cape Town)
Spain Francisco Cervantes (Barcelona)
Sweden Bengt Simonsson (Uppsala)
USA Michael Mauro (Portland)
Venezuela Jose Luis Lopez (Caracas)